TAVANTA THERAPEUTICS
Live / Registered — Registered (as of 12 Oct 2021)
What this means for you
Registered since 12 Oct 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88916837
- Registration number
- 6521716
- Mark type
- Stylized text
- Filed
- 14 May 2020
- Published for opposition
- 13 Oct 2020
- Registered
- 12 Oct 2021
- Attorney of record
- Thomas G. Peterson
Goods and services
- Class 042 — Scientific and technological services: Scientific, medical and pharmaceutical research and development, namely, development of new pharmaceutical formulations, development of pharmaceutical formulations for efficient drug release, development of clinical uses and treatments for new chemical entities and known pharmaceutical compounds; research and development of new pharmaceutical formulations; research and development of pharmaceutical formulations for efficient drug release; research and development of pharmaceuticals, namely, pharmaceuticals for treating cancer, multiple sclerosis, cystic fibrosis, tuberous sclerosis complex, and other disease states; research and development of new chemical entities and known pharmaceutical compounds; research and development of medicines, namely, for the treatment of cancer, multiple sclerosis, cystic fibrosis, tuberous sclerosis complex, and other disease states; scientific investigations for medical purposes; research and development of medicines, namely, new chemical entities and known pharmaceutical compounds
Owner
- TAVANTA THERAPEUTICS, INC., RADNOR, PA, US
- Druggability Technologies Holdings, Ltd, Dublin, IE
- Druggability Technologies Holdings, Ltd, Dublin, IE
- Druggability Technologies Holdings, Ltd, Dublin, IE
Prosecution history
- 27 Jul 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 12 Oct 2021 — REGISTERED-PRINCIPAL REGISTER
- 09 Sept 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Sept 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Aug 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Aug 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Aug 2021 — ASSIGNED TO LIE
- 30 Jul 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Jul 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Jul 2021 — NON-FINAL ACTION E-MAILED
- 21 Jul 2021 — SU - NON-FINAL ACTION - WRITTEN
- 22 Jun 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Jun 2021 — USE AMENDMENT FILED
- 17 Jun 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Jun 2021 — TEAS STATEMENT OF USE RECEIVED